Abstract
The prognosis for patients diagnosed with malignant brain tumors has remained dismal despite advances in both neuroimaging and conventional treatment modalities. The use of biodegradable polymers for controlled local delivery of antineoplastic agents represents a major advance in the treatment of brain tumors. By implanting polymers loaded with chemotherapy agents directly onto the brain tumor resection bed, therapeutic doses of a drug can be administered intracranially for prolonged periods of time meaning high systemic doses associated with debilitating toxicities can be avoided. This technological advance has expanded the spectrum of available treatments for neoplasms of the CNS and has facilitated new approaches for the treatment of malignant brain tumors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
